Headlands Technologies’s CRISPR Therapeutics CRSP Stock Holding History

Headlands Technologies’s Portfolio CRSP Stock Details CRSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell
2025 Q2	$394K	Buy
2024 Q3	–	Sell
2024 Q2	$186K	Buy
2023 Q4	–	Sell
2023 Q3	$34.2K	Buy